Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
301-313
Author(s):
Victoria E. Mendizabal and Edda Adler-Graschinsky
Cellular Actions of Gabapentin and Related Compounds on Cultured Sensory Neurones
Journal:
Current Neuropharmacology
Volume:
1
Page:
219-235
Author(s):
Roderick H. Scott, Duncan J. Martin and David McClelland
A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
525-539
Author(s):
I. Baglin, A.- C. Mitaine-Offer, M. Nour, K. Tan, C. Cave and M.- A. Lacaille-Dubois
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1607-1633
Author(s):
Patricia H. Reggio
Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Journal:
Current Gene Therapy
Volume:
3
Page:
319-339
Author(s):
M. Boyd, H. S. Spenning and R. J. Mairs
Immunophilins and Coupled Gating of Ryanodine Receptors
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1383-1391
Author(s):
Stephan E. Lehnart, Fannie Huang, Steven O. Marx and Andrew R. Marks
Death Receptor Signaling in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
253-262
Author(s):
Simone Fulda and Klaus-Michael Debatin
The Role of Iron Chelation in Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1021-1034
Author(s):
Joan L. Buss, Frank M. Torti and Suzy V. Torti
Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1035-1049
Author(s):
D. B. Lovejoy and D. R. Richardson
The MYC Oncogene as a Cancer Drug Target
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
163-175
Author(s):
Heiko Hermeking